" We see hopeful and encouraging information here , " says maria carrillo , senior director of medical and scientific relations for the alzheimer 's association .
So far , lilly has released only preliminary findings , but carrillo says they appear to be the best evidence yet that anti-amyloid therapy can slow cognitive decline in some patients .
